Morgan Stanley’s Icosavax, Inc. Common Stock ICVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-131,606
| Closed | -$2.07M | – | 8076 |
|
|
2023
Q4 | $2.07M | Buy |
131,606
+97,021
| +281% | +$1.53M | ﹤0.01% | 4901 |
|
|
2023
Q3 | $268K | Buy |
34,585
+2,807
| +9% | +$21.8K | ﹤0.01% | 5448 |
|
|
2023
Q2 | $316K | Buy |
31,778
+7,439
| +31% | +$73.9K | ﹤0.01% | 5443 |
|
|
2023
Q1 | $141K | Buy |
24,339
+3,666
| +18% | +$21.3K | ﹤0.01% | 5863 |
|
|
2022
Q4 | $164K | Buy |
20,673
+1,427
| +7% | +$11.3K | ﹤0.01% | 5748 |
|
|
2022
Q3 | $61K | Sell |
19,246
-95,348
| -83% | -$302K | ﹤0.01% | 6321 |
|
|
2022
Q2 | $657K | Buy |
114,594
+69,866
| +156% | +$401K | ﹤0.01% | 5272 |
|
|
2022
Q1 | $315K | Buy |
44,728
+3,494
| +8% | +$24.6K | ﹤0.01% | 5663 |
|
|
2021
Q4 | $944K | Buy |
41,234
+5,340
| +15% | +$122K | ﹤0.01% | 5114 |
|
|
2021
Q3 | $1.06M | Buy |
+35,894
| New | +$1.06M | ﹤0.01% | 5008 |
|